Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma

被引：0
|
作者：
Yujing Xin
Xinyuan Zhang
Ning Liu
Gang Peng
Xiaoyu Huang
Xiaojing Cao
Xiang Zhou
Xiao Li
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[2] Shandong University,School of Software
来源：
Hepatology International | 2023年 / 17卷
关键词：
Lenvatinib; PD-1 inhibitor; Transarterial chemoembolization; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：753 / 764
页数：11
相关论文
共 50 条
  • [1] Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
    Xin, Yujing
    Zhang, Xinyuan
    Liu, Ning
    Peng, Gang
    Huang, Xiaoyu
    Cao, Xiaojing
    Zhou, Xiang
    Li, Xiao
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 753 - 764
  • [2] Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis
    Chen, Yue
    Jia, Luyao
    Li, Yu
    Cui, Wenhao
    Wang, Jukun
    Zhang, Chao
    Bian, Chunjing
    Luo, Tao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular carcinoma
    Sheng, Ye
    Wang, Qing
    Liu, Haifeng
    Wang, Qi
    Chen, Wenhua
    Xing, Wei
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1155): : 668 - 679
  • [4] Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma
    Xiang, Yan-Jun
    Wang, Kang
    Yu, Hong-Ming
    Li, Xiao-Wei
    Cheng, Yu-Qiang
    Wang, Wei-Jun
    Feng, Jin-Kai
    Bo, Meng-Han
    Qin, Ying-Yi
    Zheng, Yi-Tao
    Shan, Yun-Feng
    Zhou, Li-Ping
    Zhai, Jian
    Cheng, Shu-Qun
    HEPATOLOGY RESEARCH, 2022, 52 (08) : 721 - 729
  • [5] Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
    Wang, Jinfeng
    Zhao, Man
    Han, Guangjie
    Han, Xin
    Shi, Jianfei
    Mi, Lili
    Li, Ning
    Yin, Xiaolei
    Duan, Xiaoling
    Hou, Jiaojiao
    Yin, Fei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [6] Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
    Wang, Jinfeng
    Zhao, Man
    Han, Guangjie
    Han, Xin
    Shi, Jianfei
    Mi, Lili
    Li, Ning
    Yin, Xiaolei
    Duan, Xiaoling
    Hou, Jiaojiao
    Yin, Fei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [7] The safety and efficacy of transarterial chemoembolization (TACE) plus lenvatinib plus programmed cell death protein 1 (PD-1) antibody of advanced unresectable hepatocellular carcinoma
    Zhang, Xiaoyun
    Zhu, Xinrui
    Liu, Chang
    Lu, Wusheng
    Li, Qiu
    Chen, Weixia
    Li, Zhiping
    Lu, Qiang
    Peng, Wei
    Li, Chuan
    Yan, Lvnan
    Yang, Jiayin
    Wen, Tianfu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report
    Mu, Chunyang
    Shen, Junyi
    Zhu, Xinrui
    Peng, Wei
    Zhang, Xiaoyun
    Wen, Tianfu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
    Jin, Ming
    Jiang, Zhi-qing
    Qin, Jia-hui
    Qin, Hui-xia
    Jiang, Kai-wen
    Ya, Hou-xiang
    Gu, Jing
    Gui, Mo-rui
    Li, Yao-hua
    Xu, Long-kuan
    Fu, Hai-xiao
    Xiao, Xu-hua
    Li, Shu-qun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 2309 - 2320
  • [10] Efficacy and safety of transarterial chemoembolization combined with lenvatinib and PD-1 inhibitor in the treatment of advanced hepatocellular carcinoma: A meta-analysis
    Wang, Lei
    Lin, Li
    Zhou, Wei
    PHARMACOLOGY & THERAPEUTICS, 2024, 257
12345